224 related articles for article (PubMed ID: 23029359)
1. Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma.
Laghi L; Beghelli S; Spinelli A; Bianchi P; Basso G; Di Caro G; Brecht A; Celesti G; Turri G; Bersani S; Schumacher G; Röcken C; Gräntzdörffer I; Roncalli M; Zerbi A; Neuhaus P; Bassi C; Montorsi M; Scarpa A; Malesci A
PLoS One; 2012; 7(9):e46002. PubMed ID: 23029359
[TBL] [Abstract][Full Text] [Related]
2. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
4. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.
Ashktorab H; Brim H; Al-Riyami M; Date A; Al-Mawaly K; Kashoub M; Al-Mjeni R; Smoot DT; Al-Moundhri M; Al-Hashemi S; Ganguly SS; Raeburn S
Dig Dis Sci; 2008 Oct; 53(10):2723-31. PubMed ID: 18299982
[TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach.
Hartman DJ; Brand RE; Hu H; Bahary N; Dudley B; Chiosea SI; Nikiforova MN; Pai RK
Hum Pathol; 2013 Nov; 44(11):2518-28. PubMed ID: 24034859
[TBL] [Abstract][Full Text] [Related]
6. A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations.
Pedroni M; Roncari B; Maffei S; Losi L; Scarselli A; Di Gregorio C; Marino M; Roncucci L; Benatti P; Ponti G; Rossi G; Menigatti M; Viel A; Genuardi M; de Leon MP
Dis Markers; 2007; 23(3):179-87. PubMed ID: 17473388
[TBL] [Abstract][Full Text] [Related]
7. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
[TBL] [Abstract][Full Text] [Related]
8. Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features.
Tomaszewska R; Okoń K; Stachura J
Pol J Pathol; 2003; 54(1):31-7. PubMed ID: 12817878
[TBL] [Abstract][Full Text] [Related]
9. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
11. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
[TBL] [Abstract][Full Text] [Related]
12. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases.
Lotsari JE; Gylling A; Abdel-Rahman WM; Nieminen TT; Aittomäki K; Friman M; Pitkänen R; Aarnio M; Järvinen HJ; Mecklin JP; Kuopio T; Peltomäki P
Breast Cancer Res; 2012 Jun; 14(3):R90. PubMed ID: 22691310
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers.
Egoavil C; Alenda C; Castillejo A; Paya A; Peiro G; Sánchez-Heras AB; Castillejo MI; Rojas E; Barberá VM; Cigüenza S; Lopez JA; Piñero O; Román MJ; Martínez-Escoriza JC; Guarinos C; Perez-Carbonell L; Aranda FI; Soto JL
PLoS One; 2013; 8(11):e79737. PubMed ID: 24244552
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.
Goel A; Xicola RM; Nguyen TP; Doyle BJ; Sohn VR; Bandipalliam P; Rozek LS; Reyes J; Cordero C; Balaguer F; Castells A; Jover R; Andreu M; Syngal S; Boland CR; Llor X
Gastroenterology; 2010 May; 138(5):1854-62. PubMed ID: 20102720
[TBL] [Abstract][Full Text] [Related]
17. Differences and evolution of the methods for the assessment of microsatellite instability.
Laghi L; Bianchi P; Malesci A
Oncogene; 2008 Oct; 27(49):6313-21. PubMed ID: 18679418
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability: an update.
Yamamoto H; Imai K
Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
Mueller J; Gazzoli I; Bandipalliam P; Garber JE; Syngal S; Kolodner RD
Cancer Res; 2009 Sep; 69(17):7053-61. PubMed ID: 19690142
[TBL] [Abstract][Full Text] [Related]
20. Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing.
Bartley AN; Luthra R; Saraiya DS; Urbauer DL; Broaddus RR
Cancer Prev Res (Phila); 2012 Feb; 5(2):320-7. PubMed ID: 22086678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]